Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Patients with alopecia areata have lower RBC folate levels, especially in severe cases.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Topical minoxidil can help hair regrowth in alopecia areata patients, but maintaining the growth after stopping treatment is inconsistent.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Topical cyclosporine lotion led to noticeable hair regrowth in alopecia universalis.

Yellow dots are common in severe alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

COVID-19 doesn't make alopecia areata worse.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Denosumab treatment for osteoporosis can cause hair loss.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

Leflunomide can cause severe hair loss in some rheumatoid arthritis patients.

Topical minoxidil showed limited effectiveness for hair regrowth in alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.